FDA
label_change
· 2021-02-05
FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)
Summary
The FDA approved a supplemental application for KLONOPIN (clonazepam) from H2-Pharma, LLC, resulting in changes to the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KLONOPIN (CLONAZEPAM)